The Yield Paradox: Turning Strict Protocols into Recruitment Success: In clinical development, recruitment is often judged by volume. But the reality is a “Yield Paradox”: high applicant numbers frequently lead to low enrollment efficiency and site burnout.
The Challenge: The “Eligibility Wall” In a recent early-stage breast cancer study, we saw this firsthand. While the trial generated 97 applicants, a staggering 60% were excluded due to narrow protocol windows (e.g., pre-surgery or within 3 months of radiotherapy). For patients and sponsors, this “eligibility wall” is the ultimate bottleneck.

The Solution: Intelligence-Driven Targeting: Success isn’t about more leads; it’s about Intent-Driven Search. Our analysis found that:

• Search Behavior is Predictive: Web Search (Listing Ads) yielded 55% of all qualified candidates.
• Precision Timing: Optimizing for surgery-planning keywords captured patients at the exact moment their clinical status matched the protocol.
• Expert Screening: Using trained contact centers to pre-screen inquiries reduced site burden and filtered 103 approaches down to 9 site-ready candidates.

Recruitment in Japan is evolving. With the shift toward Medical DX and the 120-minute travel threshold for oncology patients, digital precision is no longer optional—it is a requirement for overcoming the “drug loss” crisis.

Key Takeaways
・Quality > Quantity: Measure “Eligibility Yield,” not just lead volume.
・Intent Over Awareness: Target the treatment window, not just the disease.
・Expert Human-in-the-Loop: Combine digital precision with expert pre-screening to accelerate enrollment.

Strict protocols don’t limit success—poor recruitment design does. Let’s shift from broadcasting to precision intelligence.

📢 Planning your next study in Japan?
Let’s talk about how we can help.🌐 https://global-3h.com/contact-us/